|
Income Statement for
EnteroMedics Inc.
(ETRM)
|
|
|
|
|
|
|
| Income
[+]
|
in Thousands of Dollars |
|
|
| Operating Revenue |
311 |
- |
- |
- |
- |
| Total Revenue |
311 |
- |
- |
- |
- |
| Adjustments to Revenue |
N/A |
- |
- |
- |
- |
| Cost of Revenue |
(207) |
- |
(764) |
(1,916) |
(1,164) |
| Cost of Sales With Depreciation |
232 |
- |
- |
- |
- |
| Gross Margin |
80 |
- |
764 |
1,916 |
1,164 |
| Gross Operating Profit |
80 |
- |
764 |
1,916 |
1,164 |
|
| Selling/General/Admin Expense |
(11,961) |
(8,583) |
(7,678) |
(8,632) |
(8,597) |
| Research & Development |
(10,668) |
(16,673) |
(8,499) |
(15,581) |
(27,674) |
| Advertising |
- |
- |
- |
- |
- |
| EBITDA (Operating Income Before Depreciation) |
(22,558) |
(25,257) |
(15,413) |
(22,296) |
(35,107) |
| Depreciation & Amortization |
(439) |
(542) |
(764) |
(1,916) |
(1,164) |
| Depreciation, Unreconciled |
- |
- |
- |
- |
- |
| Amortization |
- |
- |
- |
- |
- |
| Amortization of Intangibles |
- |
- |
- |
- |
- |
| Operating Income |
(22,770) |
(25,799) |
(16,177) |
(24,212) |
(36,270) |
| Operating Profit After Depreciation |
(22,770) |
(25,799) |
(16,177) |
(24,212) |
(36,270) |
| Interest Income |
10 |
12 |
6 |
79 |
1,102 |
| Earnings from Equity Interest |
- |
- |
- |
- |
- |
| Other Income, Net |
(19) |
(30) |
83 |
(3,692) |
(22) |
| Income, Acquired in Process R&D |
- |
- |
- |
- |
- |
| Income, Restructuring and M&A |
- |
- |
- |
- |
- |
| Other Special Charges |
- |
- |
- |
- |
- |
| Total Income Before Interest Expense (EBIT) |
(22,558) |
(25,816) |
(16,089) |
(27,825) |
(35,190) |
| Interest Expense |
(902) |
(723) |
(1,258) |
(4,104) |
(2,684) |
| Income Before Tax |
(23,460) |
(26,539) |
(17,347) |
(31,929) |
(37,874) |
| Income Taxes |
- |
- |
- |
- |
- |
| Minority Interest |
- |
- |
- |
- |
- |
| Preferred Securities of Subsidiary Trust |
- |
- |
- |
- |
- |
| Other Special Charges |
(23,460) |
- |
- |
- |
- |
| Net Income from Continuing Operations |
(23,460) |
(25,997) |
(17,347) |
(31,929) |
(37,874) |
| Net Income from Discontinued Operations |
- |
- |
- |
- |
- |
| Net Income from Total Operations |
(23,460) |
(25,997) |
(17,347) |
(31,929) |
(37,874) |
|
| Normalized Income |
(23,460) |
(25,997) |
(17,347) |
(31,929) |
(37,874) |
| Extraordinary Income/Loss |
- |
- |
- |
- |
- |
| Special Income/Charges |
- |
- |
- |
- |
- |
| Income from Cum. Effect of Acct Change |
- |
- |
- |
- |
- |
| Income from Tax Loss Carryforward |
- |
- |
- |
- |
- |
| Net Income Available for Common |
(23,460) |
(25,997) |
(17,347) |
(31,929) |
(37,874) |
| Other Gains |
- |
- |
- |
- |
- |
| Total Net Income |
(23,460) |
(25,997) |
(17,347) |
(31,929) |
(37,874) |
| Net Income Available for Common |
(23,460) |
(25,997) |
(17,347) |
(31,929) |
(37,874) |
|
| Results
[+]
|
in Dollars (Preferred Dividends in Thousands) |
|
|
| Dividends Paid Per Share |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Preferred Dividends |
- |
- |
- |
- |
- |
| Basic EPS from Continuing Operations |
-0.59 |
-0.86 |
-2.06 |
-6.42 |
-13.50 |
| Basic EPS from Discontinued Operations |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Extraordinary Income Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Cumulative Effect of Accounting Change |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Tax Loss Carryforward |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Other Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Total Net Income |
-0.59 |
-0.86 |
-2.06 |
-6.42 |
-13.50 |
| Basic Normalized Net Income per Share |
-0.59 |
-0.86 |
-2.06 |
-6.42 |
-13.50 |
| Basic EPS from Total Operations |
-0.59 |
-0.86 |
-2.06 |
-6.42 |
-13.50 |
|
| Diluted EPS from Continuing Operations |
-0.59 |
-0.86 |
-2.06 |
-6.42 |
-13.50 |
| Diluted EPS from Discontinued Operations |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Extraordinary Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Cumulative Effect of Accounting Change |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Tax Loss Carryforward |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Other Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Total Net Income |
-0.59 |
-0.86 |
-2.06 |
-6.42 |
-13.50 |
| Diluted Normalized Net Income per Share |
-0.59 |
-0.86 |
-2.06 |
-6.42 |
-13.50 |
| Excise Tax |
- |
- |
- |
- |
- |
| Diluted EPS from Total Operations |
-0.59 |
-0.86 |
-2.06 |
-6.42 |
-13.50 |
|
|
|
